Clinical trials
Phase 3 Heart Diseases trials in New Zealand
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| GlaxoSmithKline | 2 |
| Amarin Pharma Inc. | 1 |
| CSL Behring | 1 |
| Eidos Therapeutics, a BridgeBio company | 1 |
| Novartis Pharmaceuticals | 1 |
| Rutgers, The State University of New Jersey | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Diseases | 9 |
| Cardiovascular Diseases | 6 |
| Atherosclerosis | 4 |
| Acute Coronary Syndrome | 3 |
| Coronary Artery Disease | 3 |
| Coronary Disease | 3 |
| Kidney Diseases | 2 |
| Peripheral Arterial Disease | 2 |
| Renal Insufficiency, Chronic | 2 |
| Stroke | 2 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.